Log In Sign up
The largest database of trusted experimental protocols

Si creb5

Manufactured by GenePharma
Visit Supplier
Sourced in China

Si-CREB5 is a small interfering RNA (siRNA) designed to target the CREB5 gene. It is a laboratory tool used to study the function of the CREB5 gene and its role in cellular processes.

Automatically generated - may contain errors

Lab products found in correlation

Mir con, by GenePharma (1 mentions) Anti mir con, by GenePharma (1 mentions) Lipofectamine 3000 reagent, by Thermo Fisher Scientific (1 mentions) Si con, by GenePharma (1 mentions) Lipofectamine 3000, by Thermo Fisher Scientific (1 mentions)

2 protocols using si creb5

1

Investigating circVAPA and CREB5 roles

Check if the same lab product or an alternative is used in the 5 most similar protocols
CircVAPA small interfering RNA (si-circVAPA), si-CREB5 and their negative control (si-con), miR-125a mimics (miR-125a), miR-125a inhibitor (anti-miR-125a) and their negative controls (miR-con and anti-miR-con) were provided by GenePharma (Shanghai, China). Moreover, pcDNA3.1-circVAPA (circVAPA), pcDNA3.1-CREB5 (CREB5) and pcDNA 3.1 empty vector (vector) were obtained from Genecreat (Wuhan, China). The oligonucleotide and vector were transfected in HCT116 and LOVO cells using Lipofectamine 3000 reagents (Invitrogen)based on the instruction guidelines.
Zhang X., Xu Y., Yamaguchi K., Hu J., Zhang L., Wang J., Tian J, & Chen W. (2020). Circular RNA circVAPA knockdown suppresses colorectal cancer cell growth process by regulating miR-125a/CREB5 axis. Cancer Cell International, 20, 103.
+ Open protocol
+ Expand
2

Overexpression and Knockdown of RFC2 and CREB5

Check if the same lab product or an alternative is used in the 5 most similar protocols
The overexpression plasmid of RFC2 and CREB5 (oe-RFC2 and oe-CREB5), small interfering RNA of RFC2 and CREB5 (si-RFC2 and si-CREB5), and their negative controls were obtained from GenePharma (Shanghai, China). Lipofectamine™ 3000 (Invitrogen) was used for above plasmids transfection.
Lou F, & Zhang M. (2023). RFC2 promotes aerobic glycolysis and progression of colorectal cancer. BMC Gastroenterology, 23, 353.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!